Chief Financial Officer
Greg joined The Steadman Clinic (TSC) and the Steadman Philippon Research Institute (SPRI) in October 2014 as their Chief Financial Officer. Greg has spent his entire 28 year career in various healthcare related finance roles. Prior to joining TSC and SPRI, he served as the Chief Financial Officer for ProNerve, LLC, a privately held medical services company. His responsibilities included leadership, strategic planning and development of the entire accounting and financial functions. Prior to ProNerve, he served as Chief Financial Officer for Lanx, Inc, a privately held medical device company where his responsibilities encompassed all areas of financial management, including accounting, international finance, reporting, budgeting, annual audit, taxation, forecasting, business analysis, sales invoicing, cash collections and treasury. Prior to that, Greg was the Director of Corporate Finance for Pharmion Corporation, a publicly traded global biotechnology company, where his duties included corporate accounting, management of international finance, SEC reporting, Sarbanes-Oxley compliance, budgeting, treasury and risk management. Prior to Pharmion, Greg spent nearly 12 years with U.S. Oncology, a publicly traded national physician practice management organization specializing in oncology including seven years as a Regional Director of Finance responsible for all financial activities of a $500 million, 200 physician region. Greg spent the first six years of his career in public accounting at Ernst & Young, LLP, specializing in auditing of healthcare, manufacturing and SEC clients.
Greg is currently the Treasurer of a $30 million condominium and conference center home owners association. He is also a former board member of a 501(c)3 foundation that was created to assist cancer patients who were experiencing financial hardships.
Greg received his Bachelors of Science degree in business with an emphasis in accounting from the University of Colorado – Boulder and has been a licensed CPA since 1989.